{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:42:29Z","timestamp":1787161349393,"version":"build-2736575974"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2026,8,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glaucoma and cataract are among the leading causes of visual impairment worldwide. Both are prevalent in older adults, but it remains unclear whether their association is independent of age and shared risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess whether glaucoma and its treatments are independently associated with cataract odds using a population-based sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cross-sectional analysis of UK Biobank participants recruited between 2006 and 2010. (Analysis completed in April 2026). Glaucoma and cataract were defined using self-report and International Classification of Diseases-codes from hospital and primary care records. Participants were grouped as no glaucoma, glaucoma with no recorded treatment, topical medications, laser procedures or glaucoma surgery. Multivariable logistic regression estimated cataract odds ratios (OR, 95%\u2009CI). Models adjusted for demographic variables, clinical comorbidities and ocular parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 497\u2009109 adults, glaucoma was associated with higher odds of cataract (OR 3.09, 95% CI 2.73 to 3.49, p&lt;0.01) in fully adjusted models. Odds were higher among those using topical glaucoma treatments (OR 3.14, 95% CI 2.54 to 3.89, p&lt;0.01). Participants who had undergone glaucoma surgery had the highest odds of cataract (OR 12, 95% CI 8.99 to 16.2, p&lt;0.01). Findings were consistent in sensitivity analyses using alternative case definitions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glaucoma and its management were associated with increased odds of cataract, although the adjusted analysis for the first-line laser subgroup was limited by sample size and cannot be reliably estimated. Longitudinal studies are needed; if confirmed, the results may inform cataract surveillance and timing of operation, relevant in ageing populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjo-2026-329580","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:20:20Z","timestamp":1787160020000},"page":"bjo-2026-329580","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Association of glaucoma and glaucoma treatments with cataract in the UK Biobank: a cross-sectional observational study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9345-5636","authenticated-orcid":false,"given":"Amy Yen-Chi","family":"Chen","sequence":"first","affiliation":[{"name":"Ophthalmology Department, The University of Auckland, Auckland, New Zealand"},{"name":"Ophthalmology Department, Te Whatu Ora Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldric","family":"Khoo","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The University of Auckland, Auckland, New Zealand"},{"name":"Vision Research Foundation, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Victoria","family":"Danesh-Meyer","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The University of Auckland, Auckland, New Zealand"},{"name":"Ophthalmology Department, Te Whatu Ora Health New Zealand Te Toka Tumai Auckland, Auckland, New Zealand"},{"name":"Vision Research Foundation, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5659-2701","authenticated-orcid":false,"given":"William","family":"Schierding","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The University of Auckland, Auckland, New Zealand"},{"name":"Vision Research Foundation, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2026081910200857000_bjo-2026-329580v1.1","first-page":"e144","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2026081910200857000_bjo-2026-329580v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.07.010"},{"key":"2026081910200857000_bjo-2026-329580v1.3","doi-asserted-by":"crossref","DOI":"10.3390\/genes15040413","article-title":"Causal associations of glaucoma and age-related macular degeneration with cataract: a bidirectional two-sample Mendelian randomisation study","volume":"15","author":"Seo","year":"2024","journal-title":"Genes (Basel)"},{"key":"2026081910200857000_bjo-2026-329580v1.4","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.714"},{"key":"2026081910200857000_bjo-2026-329580v1.5","doi-asserted-by":"crossref","first-page":"11973","DOI":"10.1038\/s41598-023-38229-z","article-title":"Risk of cataract and glaucoma among older persons with diabetes in India: a cross-sectional study based on LASI, Wave-1","volume":"13","author":"Khan","year":"2023","journal-title":"Sci Rep"},{"key":"2026081910200857000_bjo-2026-329580v1.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114012","article-title":"Hypertension and risk of cataract: a meta-analysis","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS ONE"},{"key":"2026081910200857000_bjo-2026-329580v1.7","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200408000-00010"},{"key":"2026081910200857000_bjo-2026-329580v1.8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5005\/jp-journals-10028-1234","article-title":"Long-term follow-up of patients receiving intraocular pressure-lowering medications as cataract surgery candidates: a case-control study","volume":"11","author":"Bontzos","year":"2017","journal-title":"J Curr Glaucoma Pract"},{"key":"2026081910200857000_bjo-2026-329580v1.9","first-page":"599","article-title":"Does long-term administration of a beta-blocker (timolol) induce fibril-based cataract formation in vivo?","volume":"13","author":"Nikbakht","year":"2014","journal-title":"Iran K Pharm Res"},{"key":"2026081910200857000_bjo-2026-329580v1.10","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32835ab55f"},{"key":"2026081910200857000_bjo-2026-329580v1.11","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.12.1771"},{"key":"2026081910200857000_bjo-2026-329580v1.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.153379"},{"key":"2026081910200857000_bjo-2026-329580v1.13","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jcrs.2019.05.053","article-title":"Crystalline lens changes after selective laser trabeculoplasty in Afro-Caribbean patients with open-angle glaucoma; report 4 of the West Indies Glaucoma Laser Study (WIGLS)","volume":"45","author":"Realini","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"2026081910200857000_bjo-2026-329580v1.14","first-page":"84","article-title":"The effect of trabeculectomy on cataract formation or progression","volume":"4","author":"Rajavi","year":"2009","journal-title":"J Ophthalmic Vis Res"},{"key":"2026081910200857000_bjo-2026-329580v1.15","unstructured":"Biobank UK . UK biobank study. n.d. Available: https:\/\/biobank.ndph.ox.ac.uk\/showcase"},{"key":"2026081910200857000_bjo-2026-329580v1.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025077","article-title":"Cohort profile: design and methods in the eye and vision consortium of UK Biobank","volume":"9","author":"Chua","year":"2019","journal-title":"BMJ Open"},{"key":"2026081910200857000_bjo-2026-329580v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61602-x"},{"key":"2026081910200857000_bjo-2026-329580v1.18","unstructured":"Joint Formulary Committee . British National Formulary (BNF) 80th Edition. BMJ Group and Pharmaceutical Press, 2020."},{"key":"2026081910200857000_bjo-2026-329580v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.01.042"},{"key":"2026081910200857000_bjo-2026-329580v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0556-y"},{"key":"2026081910200857000_bjo-2026-329580v1.21","unstructured":"R Core Team . R: a language and environment for statistical computing. Available: https:\/\/www.r-project.org\/ [Accessed 7 Nov 2025]."},{"key":"2026081910200857000_bjo-2026-329580v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2017.01.005"},{"key":"2026081910200857000_bjo-2026-329580v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.02.013"},{"key":"2026081910200857000_bjo-2026-329580v1.24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00061198-199706000-00010","article-title":"Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies","volume":"6","author":"Chen","year":"1997","journal-title":"J Glaucoma"},{"key":"2026081910200857000_bjo-2026-329580v1.25","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1038\/s41598-018-34627-w","article-title":"Randomised clinical trial for postoperative complications after Ex-PRESS implantation versus trabeculectomy with 2-year follow-up","volume":"8","author":"Arimura","year":"2018","journal-title":"Sci Rep"},{"key":"2026081910200857000_bjo-2026-329580v1.26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"The Lancet"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2026-329580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:20:22Z","timestamp":1787160022000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2026-329580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":26,"alternative-id":["10.1136\/bjo-2026-329580"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2026-329580","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}